HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Hantz, O. Articles by Zoulim, F. Search for Related Content PubMed PubMed Citation Articles by Hantz, O. Articles by Zoulim, F. Agricola Articles by Hantz, O. Articles by Zoulim, F.

Persistence of the hepatitis B virus covalently closed circular DNA in HepaRG human hepatocyte-like cells

R. Parent^1,2,

¹ INSERM, U871, 69003 Lyon, France
² Université Lyon 1, IFR62 Lyon-Est, F-69008 Lyon, France
³ INSERM, U522, Hôpital Pontchaillou, F-35033 Rennes, France
⁴ Hospices civils de Lyon, Hôtel Dieu, Service d'Hépatologie, Lyon F-69002, France

Correspondence
O. Hantz
olivier.hantz{at}inserm.fr

The recently described hepatic cell line HepaRG is the sole hepatoma cell line susceptible to hepatitis B virus (HBV) infection. It provides a unique tool for investigating some unresolved issues of the virus' biology, particularly the formation of the viral mini-chromosome believed to be responsible for the persistence of infection. In this study, we characterized the main features of HBV infection: it is restricted to a subpopulation of differentiated hepatocyte-like cells that express albumin as a functional marker and represents around 10 % of all differentiated HepaRG cells. Infection may persist for more than 100 days in cells maintained at the differentiated state. Even though infected cells continued to produce infectious viral particles, very limited or no spreading of infection was observed. Low genetic variation was also observed in the viral DNA from viruses found in the supernatant of infected cells, although this cannot explain the lack of reinfection. HBV infection of HepaRG cells appears to be a very slow process: viral replication starts at around day 8 post-infection and reaches a maximum at day 13. Analysis of viral DNA showed slow and inefficient conversion of the input relaxed circular DNA into covalently closed circular (CCC) DNA, but no further amplification. Continuous lamivudine treatment inhibited viral replication, but neither prevented viral infection nor initial formation of CCC DNA. In conclusion, HBV infection in differentiated HepaRG cells is characterized by long-term persistence without a key feature of hepadnaviruses, the so-called ‘CCC DNA amplification’ described in the duck hepatitis B model.

Present address: Beretta Laboratory, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, M5-A841, Seattle, WA 98109, USA.